Search by Drug Name or NDC

    NDC 63323-0371-19 Daptomycin 500 mg/10mL Details

    Daptomycin 500 mg/10mL

    Daptomycin is a INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fresenius Kabi USA, LLC. The primary component is DAPTOMYCIN.

    Product Information

    NDC 63323-0371
    Product ID 63323-371_b1854217-71fa-48a4-9279-928e663eb5ec
    Associated GPIs 16270030002140
    GCN Sequence Number 053190
    GCN Sequence Number Description daptomycin VIAL 500 MG INTRAVEN
    HIC3 W9B
    HIC3 Description CYCLIC LIPOPEPTIDES
    GCN 20569
    HICL Sequence Number 025673
    HICL Sequence Number Description DAPTOMYCIN
    Brand/Generic Generic
    Proprietary Name Daptomycin
    Proprietary Name Suffix n/a
    Non-Proprietary Name Daptomycin
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
    Route INTRAVENOUS
    Active Ingredient Strength 500
    Active Ingredient Units mg/10mL
    Substance Name DAPTOMYCIN
    Labeler Name Fresenius Kabi USA, LLC
    Pharmaceutical Class Lipopeptide Antibacterial [EPC], Lipopeptides [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA206077
    Listing Certified Through 2024-12-31

    Package

    NDC 63323-0371-19 (63323037119)

    NDC Package Code 63323-371-19
    Billing NDC 63323037119
    Package 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-371-19) / 10 mL in 1 VIAL, SINGLE-DOSE
    Marketing Start Date 2018-04-11
    NDC Exclude Flag N
    Pricing Information N/A